Staggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed & Carboplatin (PC) for Metastatic Non-Squamous NSCLC

Condition:   Non-Small Cell Lung Cancer Metastatic Interventions:   Drug: Durvalumab;   Drug: Pemetrexed;   Drug: Carboplatin Sponsors:   University of Utah;   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials